SC
CGEM icon

Steven Cohen’s Cullinan Oncology CGEM Stock Holding History

Steven Cohen’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Sell
75,009
-830,367
-92% -$12.3M ﹤0.01% 2630
2026
Q1 		$12.9M Buy
905,376
+545,214
+151% +$7.01M 0.02% 1070
2025
Q4 		$3.73M Buy
+360,162
New +$3.25M ﹤0.01% 2049
2023
Q4 		– Sell
-224
Closed -$2.03K – 2236
2023
Q3 		$2.03K Sell
224
-1,801
-89% -$18.8K ﹤0.01% 2364
2023
Q2 		$21.8K Buy
+2,025
New +$21.5K ﹤0.01% 1767

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Steven Cohen's CGEM Position: Q2 2026 in Review

Steven Cohen reduced its Cullinan Oncology (CGEM) stake by 92% in Q2 2026, selling an estimated $12.3M and leaving 75,009 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2630.

Steven Cohen first reported a position in CGEM in Q2 2023 and has held it in 5 quarters since. The position peaked at $12.9M in Q1 2026. 182 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Steven Cohen held 75,009 shares of Cullinan Oncology worth $1.37M as of Q2 2026.
  • Steven Cohen sold 830,367 Cullinan Oncology shares in Q2 2026, an estimated $12.3M.
  • Cullinan Oncology made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2630 holding.
  • Steven Cohen first reported a position in Cullinan Oncology in Q2 2023 and has held it in 5 quarters since.
  • Steven Cohen's Cullinan Oncology position peaked at $12.9M in Q1 2026.
  • 182 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.